Molecular portraits of human breast tumours
Top Cited Papers
- 17 August 2000
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 406 (6797) , 747-752
- https://doi.org/10.1038/35021093
Abstract
Human breast tumours are diverse in their natural history and in their responsiveness to treatments1. Variation in transcriptional programs accounts for much of the biological diversity of human cells and tumours. In each cell, signal transduction and regulatory systems transduce information from the cell's identity to its environmental status, thereby controlling the level of expression of every gene in the genome. Here we have characterized variation in gene expression patterns in a set of 65 surgical specimens of human breast tumours from 42 different individuals, using complementary DNA microarrays representing 8,102 human genes. These patterns provided a distinctive molecular portrait of each tumour. Twenty of the tumours were sampled twice, before and after a 16-week course of doxorubicin chemotherapy, and two tumours were paired with a lymph node metastasis from the same patient. Gene expression patterns in two tumour samples from the same individual were almost always more similar to each other than either was to any other sample. Sets of co-expressed genes were identified for which variation in messenger RNA levels could be related to specific features of physiological variation. The tumours could be classified into subtypes distinguished by pervasive differences in their gene expression patterns.Keywords
This publication has 20 references indexed in Scilit:
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- [12] DNA arrays for analysis of gene expressionPublished by Elsevier ,1999
- Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic ScaleScience, 1997
- Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patientsNature Medicine, 1996
- Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptorsEuropean Journal Of Cancer, 1992
- Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancerInternational Journal of Cancer, 1988
- MONOCLONAL MARKER THAT PREDICTS EARLY RECURRENCE OF BREAST CANCERThe Lancet, 1987
- Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells.Journal of Histochemistry & Cytochemistry, 1986